This mechanism inhibits the increased expression of CXCL1 and also CXCL2, S100 calcium binding protein A8 (S100A8) and S100 calcium binding protein A9 (S100A9), which suppresses the formation of liver steatosis and HCC. This evidence concerns the gene S100A9 and hepatocellular carcinoma.